Universal vaccination of healthy children against influenza: a role for the cold-adapted intranasal influenza vaccine (Q34511035)

2 August 2017

1 reference

title

Universal vaccination of healthy children against influenza: a role for the cold-adapted intranasal influenza vaccine (English)

1 reference

2 August 2017

0 references

2

Gregory A Poland

1 reference

2 August 2017

Robert M Jacobson

1

1 reference

PubMed ID

11817987

2 August 2017

language of work or name

1 reference

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

4

1 reference

2 August 2017

1

1 reference

2 August 2017

65-71

1 reference

https://scigraph.springernature.com/pub.10.2165/00128072-200204010-00007

2 August 2017

0 references

cites work

The potential advantages and requirements of live attenuated influenza virus vaccines

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200204010-00007

Live attenuated influenza A virus vaccines in children: results of a field trial

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200204010-00007

Safety and immunogenicity of live attenuated cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in infants and children

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00128072-200204010-00007

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

21 January 2018

1 reference

12 December 2020

Evaluation of a cold-adapted influenza B/Texas/84 reassortant virus (CRB-87) vaccine in young children

1 reference

12 December 2020

Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children

1 reference

12 December 2020

Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team

1 reference

12 December 2020

Influenza and the rates of hospitalization for respiratory disease among infants and young children

1 reference

12 December 2020

Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review

1 reference

12 December 2020

Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults

1 reference

12 December 2020

Estimating household and community transmission parameters for influenza.

1 reference

12 December 2020

The Japanese experience with vaccinating schoolchildren against influenza

1 reference

12 December 2020

Influenza vaccination in the prevention of acute otitis media in children

1 reference

12 December 2020

Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981

1 reference

12 December 2020

The impact of influenza vaccination on respiratory illness at a boarding school

1 reference

12 December 2020

Influenzavirus infections in Seattle families, 1975-1979. I. Study design, methods and the occurrence of infections by time and age

1 reference

12 December 2020

Vaccine manufacture at the time of a pandemic influenza

1 reference

12 December 2020

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

12 December 2020

Modification of an Outbreak of Influenza in Tecumseh, Michigan by Vaccination of Schoolchildren

1 reference

12 December 2020

Intranasal influenza vaccine: adding to the armamentarium for influenza control

1 reference

12 December 2020

Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic

1 reference

12 December 2020

Japan lagging in influenza jabs

1 reference

12 December 2020

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

1 reference

12 December 2020

Statistical inference for infectious diseases. Risk-specific household and community transmission parameters

1 reference

12 December 2020

Safety of and serum antibody response to cold-recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases

1 reference

12 December 2020

Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts

1 reference

12 December 2020

Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza

1 reference

12 December 2020

Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial

1 reference

12 December 2020

Use of temperature-sensitive and cold-adapted mutant viruses in immunoprophylaxis of acute respiratory tract disease

1 reference

12 December 2020

An influenza simulation model for immunization studies

1 reference

12 December 2020

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control

1 reference

12 December 2020

Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine

1 reference

12 December 2020

Underused options for preventing and treating influenza.

1 reference

12 December 2020

Local and systemic antibody responses in high-risk adults given live-attenuated and inactivated influenza A virus vaccines

1 reference

12 December 2020

Influenza vaccination of high-risk children: a survey of three physician groups

1 reference

12 December 2020

Scepticism about influenza vaccine efficacy in Japan

1 reference

12 December 2020

New epidemiologic evidence confirming that bias does not explain the aspirin/Reye's syndrome association

1 reference

12 December 2020

Routine and influenza vaccination rates in children with asthma

1 reference

12 December 2020

Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care

1 reference

12 December 2020

Enhanced lymphoproliferation to influenza A virus following vaccination of older, chronically ill adults with live-attenuated viruses

1 reference

12 December 2020

Multidose, live attenuated, cold-recombinant, trivalent influenza vaccine in infants and young children

1 reference

12 December 2020

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine

1 reference

12 December 2020

A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease

1 reference

12 December 2020

Effect of vaccination of a school-age population upon the course of an A2-Hong Kong influenza epidemic

1 reference

12 December 2020

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

1 reference

12 December 2020

Influenza immunization of schoolchildren: can we interrupt community epidemics?

1 reference

12 December 2020

Influenza surveillance in community-dwelling elderly compared with children.

1 reference

12 December 2020

Evaluation of cold-recombinant influenza A/Korea (CR-59) virus vaccine in infants

1 reference

12 December 2020

THE EPIDEMIOLOGICAL BASIS FOR THE CONTROL OF INFLUENZA

1 reference

12 December 2020

Potential cost savings attributable to influenza vaccination of school-aged children

1 reference

12 December 2020

10.2165/00128072-200204010-00007

Identifiers

DOI

1 reference

PubMed ID

11817987

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

11817987